Matthew D Wood

8PUBLICATIONS
93CO-AUTHORS
Immunogenetics (incl. genetic immunology)Haematological tumoursEpigenetics (incl. genome methylation and epigenomics)Gene expression (incl. microarray and other genome-wide approaches)Neurogenetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Oct 12, 2023
Combined Immunotherapy Improves Outcome for Replication-Repair-Deficient (RRD) High-Grade Glioma Failing Anti-PD-1 Monotherapy: A Report from the International RRD Consortium.

Anirban Das, Nicholas R Fernandez, Adrian Levine

|Sep 05, 2023
Molecular profiling of pre- and post-treatment pediatric high-grade astrocytomas reveals acquired increased tumor mutation burden in a subset of recurrences.

Matthew D Wood, Carol Beadling, Tanaya Neff

|Dec 09, 2020
Post-treatment hypermutation in a recurrent diffuse glioma with H3.3 p.G34 Mutation.

Matthew D Wood, Tanaya Neff, Joshua P Nickerson

|Apr 03, 2020
Infant High-Grade Gliomas Comprise Multiple Subgroups Characterized by Novel Targetable Gene Fusions and Favorable Outcomes.

Matthew Clarke, Alan Mackay, Britta Ismer

|Jul 11, 2019
An unusual recurrent high-grade glioneuronal tumor with MAP2K1 mutation and CDKN2A/B homozygous deletion.

Barry Cheaney, Stephen Bowden, Katie Krause

|Apr 11, 2019
Applications of molecular neuro-oncology - a review of diffuse glioma integrated diagnosis and emerging molecular entities.

Matthew D Wood, Aaron M Halfpenny, Stephen R Moore

Pageof 2

Frequent Collaborators

2 joint publications

David A Solomon

2 joint publications

Fernando Carceller

1 joint publications

Jessica C Pickles

1 joint publications

Tejus A Bale